Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 474.60%48.8M | 136.79%19.66M | 199.84%6.86M | 543.18%25.72M | 60.34%-3.44M | 71.57%-13.03M | 305.80%8.3M | 51.91%-6.87M | 36.19%-5.8M | 52.94%-8.66M |
Net income from continuing operations | 241.70%35.46M | 70.11%6.86M | 116.58%4.22M | 1,318.18%12.19M | 562.71%12.2M | 30.92%-25.03M | 159.99%4.03M | -242.34%-25.42M | 91.31%-1M | 75.04%-2.64M |
Operating gains losses | 299.42%682K | 305.43%945K | -272.76%-463K | 107.69%1K | 245.26%199K | -118.88%-342K | 23.84%-460K | -80.59%268K | -101.59%-13K | -164.02%-137K |
Depreciation and amortization | 141.63%19.76M | 57.56%5.68M | 173.48%5.18M | 230.39%4.6M | 234.27%4.3M | 135.11%8.18M | 180.54%3.61M | 112.46%1.89M | 75.09%1.39M | 153.85%1.29M |
Deferred tax | --0 | --0 | ---- | ---- | ---- | ---1.66M | ---120K | ---- | ---- | ---- |
Other non cash items | -84.61%4.68M | 15.05%1.25M | -95.64%1.23M | 53.55%1.1M | 268.01%1.09M | 2,470.30%30.38M | 217.60%1.08M | 13,303.79%28.28M | 128.25%719K | -5.71%297K |
Change In working capital | -1.47%-45M | -4.91%-5.83M | 27.60%-11.25M | 101.49%177K | -146.61%-28.1M | -65.73%-44.35M | -318.60%-5.56M | -28.88%-15.54M | -505.62%-11.86M | 0.22%-11.39M |
-Change in receivables | -1.46%-34.31M | -178.15%-7.84M | 20.80%-8.82M | 108.51%757K | -67.92%-18.41M | -55.99%-33.82M | 47.71%-2.82M | -21.61%-11.14M | -570.69%-8.9M | -88.87%-10.96M |
-Change in inventory | 70.27%-8.35M | 158.57%4.14M | 54.66%-4.56M | 68.47%-2.32M | -54.93%-5.61M | -250.10%-28.09M | -265.96%-7.06M | -417.88%-10.05M | -499.35%-7.35M | -23.82%-3.62M |
-Change in prepaid assets | -198.05%-6.26M | -384.06%-196K | -6.11%-2.85M | -217.30%-1.64M | -78.28%-1.58M | -183.34%-2.1M | -97.37%69K | -354.50%-2.69M | 212.73%1.4M | -1,104.55%-884K |
-Change in payables and accrued expense | -69.15%6.54M | -115.05%-814K | -37.60%4.95M | 32.74%4.5M | -146.59%-2.09M | 12,598.80%21.21M | 45.83%5.41M | 570.56%7.93M | 56.81%3.39M | 211.58%4.48M |
-Change in other current assets | -175.93%-149K | ---49K | ---76K | --0 | 55.56%-24K | ---54K | --0 | --0 | --0 | ---54K |
-Change in other current liabilities | -43.90%-2.27M | -35.10%-639K | -74.37%-626K | -29.23%-504K | -40.91%-496K | -717.25%-1.57M | -41.19%-473K | -9.45%-359K | -20.74%-390K | -128.36%-352K |
-Change in other working capital | -344.58%-203K | 36.95%-430K | --731K | ---612K | --108K | --83K | ---682K | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 474.60%48.8M | 136.79%19.66M | 199.84%6.86M | 543.18%25.72M | 60.34%-3.44M | 71.57%-13.03M | 305.80%8.3M | 51.91%-6.87M | 36.19%-5.8M | 52.94%-8.66M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 33.33%-129.3M | 67.46%-13.61M | 68.12%-47.76M | -1,621.96%-23.76M | -4,665.05%-44.17M | -455.79%-193.95M | -1,412.95%-41.82M | -705.41%-149.83M | -106.27%-1.38M | -108.82%-927K |
Net PPE purchase and sale | 14.56%-129.74M | 67.46%-13.61M | 55.25%-48.2M | -1,621.96%-23.76M | -4,665.05%-44.17M | -1,175.28%-151.85M | -1,412.95%-41.82M | -3,576.52%-107.72M | 67.61%-1.38M | 52.53%-927K |
Net intangibles purchase and sale | --0 | --0 | ---- | ---- | ---- | ---27.21M | --0 | ---- | ---- | ---- |
Net business purchase and sale | 102.96%441K | --0 | ---- | ---- | ---- | ---14.89M | --0 | ---- | ---- | ---- |
Net investment purchase and sale | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 33.33%-129.3M | 67.46%-13.61M | 68.12%-47.76M | -1,621.96%-23.76M | -4,665.05%-44.17M | -455.79%-193.95M | -1,412.95%-41.82M | -705.41%-149.83M | -106.27%-1.38M | -108.82%-927K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -94.29%22.87M | 28.35%1.19M | 416.22%7.86M | -97.30%10.64M | -19.53%3.19M | 138.45%400.42M | -69.85%924K | -99.07%1.52M | 166,150.21%394.01M | 877.28%3.96M |
Net issuance payments of debt | --0 | --0 | --0 | ---- | ---- | 1,883.08%445.38M | --0 | --0 | ---- | ---- |
Net common stock issuance | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Proceeds from stock option exercised by employees | 221.72%22.87M | 28.35%1.19M | 416.22%7.86M | 1,409.36%10.64M | -19.53%3.19M | 26.65%7.11M | -71.35%924K | -12.82%1.52M | 197.47%705K | 877.28%3.96M |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---52.07M | --0 | --0 | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -94.29%22.87M | 28.35%1.19M | 416.22%7.86M | -97.30%10.64M | -19.53%3.19M | 138.45%400.42M | -69.85%924K | -99.07%1.52M | 166,150.21%394.01M | 877.28%3.96M |
Net cash flow | ||||||||||
Beginning cash position | 96.01%395.31M | -22.69%330.59M | -37.69%363.25M | 78.82%350.72M | 96.01%395.31M | 673.32%201.68M | 108.63%427.61M | 1,787.46%582.96M | 966.07%196.13M | 673.32%201.68M |
Current changes in cash | -129.79%-57.63M | 122.22%7.24M | 78.71%-33.04M | -96.74%12.6M | -689.02%-44.42M | 9.52%193.44M | -772.79%-32.59M | -188.83%-155.17M | 2,839.88%386.83M | 24.80%-5.63M |
Effect of exchange rate changes | -377.72%-536K | -335.27%-687K | 318.08%386K | -1,340.00%-62K | -336.99%-173K | 118.90%193K | -35.68%292K | 70.98%-177K | 100.75%5K | 137.24%73K |
End cash Position | -14.71%337.15M | -14.71%337.15M | -22.69%330.59M | -37.69%363.25M | 78.82%350.72M | 96.01%395.31M | 96.01%395.31M | 108.63%427.61M | 1,787.46%582.96M | 966.07%196.13M |
Free cash flow | 57.86%-80.94M | 118.07%6.06M | 70.84%-41.35M | 127.22%1.96M | -396.53%-47.61M | -232.77%-192.09M | -392.93%-33.51M | -723.86%-141.8M | 46.21%-7.18M | 52.91%-9.59M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |